Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Alligator Bioscience AB Interim report January-September 2019

"We are now regaining the exclusive, global rights to develop and commercialize ADC-1013 and at the same time receive enough ADC-1013 substance to, with or without a new partner, bring ADC-1013 into Phase II clinical trials next year. In total, we now have three projects in clinical development, and soon another one where the first patient in Phase I will be dosed”, commented CEO Per Norlén. Significant events July-September• Alligator regains the global rights for the CD40 antibody ADC-1013 (mitazalimab) from Janssen.• Alligator continued its work on the clinical development plan

Attendo’s report for the third quarter 2019: Stable performance despite challenges

Attendo shows good growth but continued pressure on margins in the third quarter of 2019. The quarter was marked by a more stable cost development and increased new sales. In Finland, a number of measures have been taken to strengthen the operations long-term, increase satisfaction and restore profitability. During the quarter, Attendo has agreed on a new long-term loan financing with more flexible terms.President and CEO Martin Tivéus comments on the report “Attendo delivers good growth and stable results, given challenging conditions. We have initiated the turn-around programme in

Interim Report January–September 2019

Strong order intake and launches for the future “Order intake increased by 52 percent, with strong contributions from both Assembly Solutions and Pattern Generators. The third quarter signaled the launch of Evo, Mycronic’s new control platform, which will form a cornerstone of our mask writers and strengthen our customer offering. After the end of the quarter, SLX was launched, which is Mycronic’s new mask writer for the semiconductor market,” says Anders Lindqvist, President and CEO. Third quarter · Order intake increased 52 percent to SEK 1,238 (813) million · Net sales

Higher net sales and stable operating profit

Peab´s Quarterly report January – September 2019July – September 2019 · Net sales SEK 13,001 million (12,445) · Operating profit SEK 727 million (743). Charged with SEK 40 millionreferring to acquisition costs from the deal with YIT · Operating margin 5.6 percent (6.0) · Pre-tax profit SEK 706 million (750) · Earnings per share SEK 2.00 (2.05) · Orders received SEK 9,349 million (11,473) · Cash flow before financing SEK -341 million (-876) January – September 2019 · Net sales SEK 38,696 million (37,388) · Operating profit SEK 1,813 million (1,710) ·

SEMCON INTERIM REPORT JANUARY-SEPTEMBER 2019

Significantly improved earningsThird quarter · The operating income amounted to SEK 410 million (405) and the organic growth was 1.6%. · The operating profit amounted to SEK 32 million (18), yielding an operating margin of 7.8% (4.4) · The profit after tax amounted to SEK 24 million (14) · Earnings per share (EPS) after dilution amounted to SEK 1.34 (0.75) January-September · The operating income amounted to SEK 1,369 million (1,353) and the organic growth was 0.6%. · The operating profit amounted to SEK 93 million (79), yielding an operating margin of 6.8% (5.8)

REPORT ON THE THIRD QUARTER 2019

· Net sales for the quarter were SEK 4,605 m (4,501); an increase of 2%, of which -6% was organic growth. · Operating profit before depreciation and amortization (EBITDA) for the quarter was SEK 792 m (835), representing a margin of 17.2% (18.6%). · Operating profit (EBIT) for the quarter was SEK 583 m (702), representing a margin of 12.7% (15.6%). · Items affecting comparability in the quarter were SEK -37 m (-) and related to initial restructuring measures executed in Q3. · Operating profit (EBIT) before items affecting comparability for the quarter was SEK 619 m (702),

Clavister Appoints Håkan Rippe as new CFO

Former CFO of Enea joins Clavister, bringing solid financial stewardship and experience.Örnsköldsvik, Sweden, October 24th, 2019. Clavister, a leader in high-performance cybersecurity solutions, welcomes Håkan Rippe as new CFO to the company, effective 1st of November. Rippe is a proven financial leader with a depth of knowledge and proven experience in the tech and software sector.  At Enea, he was instrumental in helping the company achieve seven consecutive years of EBITDA growth as well as executing billion sized debt and equity financing. Rippe was also project lead for Enea’s

DDM Holding AG and DDM Debt AB to report third quarter and YTD January – September 2019

DDM Holding AG (First North Growth Market: DDM) and its subsidiary DDM Debt AB (Nasdaq Stockholm: DDM2) will publish their Q3 and YTD January – September 2019 interim reports on Thursday 7 November 2019 at 08:00 CET. Mr. Henrik Wennerholm, CEO, and Mr. Fredrik Olsson, CFO, will host a conference call the same day, beginning at 10:00 CET, to present and comment on the DDM Group’s financial results. The conference will be held in English and can be followed live on www.ddm-group.ch  or by telephone with dial-in numbers: Sweden: +46 8 505 583

Interim report January – September 2019

Continued positive growth in Accessibility. Patient Handling Institutional US and Brexit uncertainties impact revenues. The Board has initiated a strategic review aimed to uncover underlying value Third quarter 2019 · Revenue amounted to MEUR 65.6 (65.2) · Organic growth was 0.2% (0.4) · The gross margin was 41.2% (44.0) · Adjusted EBITA amounted to MEUR 4.7 (5.9), corresponding to a margin of 7.2% (9.1) · EBIT amounted to MEUR 3.2 (4.5), corresponding to a margin of 4.9% (6.9) · Net profit (including discontinued operations) amounted to MEUR 3.9 (3.5) · Earnings

AstraZeneca year-to-date and Q3 2019 results

AstraZeneca PLC 24 October 2019 07:00 BST Year-to-date and Q3 2019 results Patients to benefit from further pipeline progress; sales-growth momentum driving operating leverage Year-to-date Product Sales growth of 13% (17% at CER[1]) to $17,315m included third-quarter Product Sales of $6,132m (+16%, +18% at CER). The third quarter again saw all three therapy areas and every sales region produce encouraging performances, including: · The continued performance of new medicines[2],[ ]with sales growth in the quarter of 62% (+64% at CER) to $2,707m, including new-medicine growth

Citycon Oyj’s Interim Report for 1 January – 30 September 2019: Another solid quarter

Citycon Oyj   Interim Report   24 October 2019 at 09:00 hrs- Solid overall performance in January-September- Total tenant sales grew by 4%; like-for-like sales by 1%- Total footfall increased by 5%; like-for-like footfall by 1%- Net rental income continued to grow, including like-for-like net rental income growth- Continued positive leasing spread driven by Sweden- Outlook narrowed after solid January-September performance and completed disposals JULY—SEPTEMBER 2019 - Net rental income was EUR 54.2 million (Q3/2018: 53.6). Development project in Mölndal coming online

Kesko’s interim report for the period 1 Jan. to 30 Sept. 2019 All-time best quarter

FINANCIAL PERFORMANCE IN BRIEF, CONTINUING OPERATIONS:                                     · Group net sales in January-September totalled €7,986.1 million (€7,727.6 million), an increase of 1.6% in comparable terms, reported net sales grew by 3.3% · Comparable operating profit totalled €331.9 million (€314.0 million) · Operating profit totalled €320.1 million (€300.5 million) · Comparable return on capital employed was 9.6% (9.8% in 1-12/2018) (rolling 12 months) · Comparable profit before tax totalled €263.1 million (€234.5 million) · Comparable earnings per share

Ahlstrom-Munksjö’s offers broad range of FluoroFree® grease-proof food packaging on a global scale

AHLSTROM-MUNKSJÖ OYJ PRESS RELEASE OCTOBER 24, 2019 at 9:00 EEST Ahlstrom-Munksjö, a global leader in innovative fiber-based solutions, launches its enhancements in the Grease-Gard® family of brands, including its expanded global offering of Grease-Gard® FluoroFree® technology. Grease-Gard® FluoroFree® delivers outstanding grease-resistance for common fast-food packaging, food wraps, clamshells, and microwave popcorn bags, without the use of fluorochemicals, commonly referred to as PFAS.“Due to our continuously improving innovation in the area of PFAS-free food packaging, Ahlstrom-

Stable result for Södra despite a weakened market

Södra reported operating profit of SEK 2,520 million for the first nine months of 2019, compared with SEK 3,533 million for the year-earlier period. Return on capital employed was 16 percent.For the third quarter, operating profit totalled SEK 512 million, compared with SEK 1,277 million in 2018.  “Operating profit for the first nine months of the year was satisfactory but was lower for the third quarter than the very strong result in the year-earlier period. But it compares favourably in view of the prevailing situation in terms of economic sentiment, demand and market prices,” said

Transcom Holding AB (publ): Invitation to Transcom third quarter 2019 results presentation

Transcom are pleased to invite you to their Q3 2019 financial update call on Thursday, November 7, 2019 at 9:00 CET, following the release of Q3 2019 results at 8:00 am CET. The press release will include the presentation for the call. The materials will also be available on https://www.transcom.com/en/investor-relations. Representing Transcom Michael Weinreich, President & CEO Jonas Dahlberg, CFO Presentation details Date/Time: Thursday, November 7, 2019 at 9:00 CET Online Registration link: http://emea.directeventreg.com/registration/3877155 Important note: Please

Fortum January-September 2019 Interim Report: Strong results improvement and agreement on majority stake in Uniper

FORTUM CORPORATION INTERIM REPORT JANUARY-SEPTEMBER 2019 24 OCTOBER 2019 AT 9:00 EEST This release is a summary of Fortum’s January-September 2019 Interim Report. The complete report is attached to this release as a pdf-file. It is also available on the company's website at www.fortum.com/investors. July-September 2019 ·  Comparable EBITDA was EUR 295 (230) million, +28% ·  Comparable operating profit was EUR 153 (96) million, +59% ·  Operating profit was EUR 124 (91) million, +36% ·  Share of profits of associated companies and joint ventures was EUR 106 (12) million,

Orexo Interim Report Q3 2019

Strong financials paving the way for broadening the business Q3 2019 highlights · Total net revenues of SEK 231.2 million (216.6), up 6.7 percent · Zubsolv® US net revenues of SEK 182.7 million (165.4), up 10.4 percent in SEK and 3.0 percent in local currency · EBITDA of SEK 114.1 million (39.8), up 186.7 percent. EBITDA ex Abstral® of SEK 71.7 million (-8.9). · US EBIT of SEK 93.4 million (55.6), up 68.0 percent · Cash flow from operating activities of SEK 135.7 million (24.5), building a cash balance of SEK 812.9 million (516.6) · Net earnings of SEK 111.7 million (

Interim Report January – September 2019

BioArctic: Strong continued progress year to date Summary of key events for the third quarter 2019 ·BioArctic and Eisai presented new data regarding BAN2401 at the Alzheimer’s Association International Conference® (AAIC®) in July that confirmed BAN2401’s unique characteristics and was consistent with previously presented results Key events after the period ·There are no key events to report after the period   Financial summary for the period January – September 2019 · Net revenues for the period increased by MSEK 56.7 to MSEK 255.4 (198.6), primarily attributable

Notice to extraordinary general meeting in Azelio AB (publ)

The shareholders in Azelio AB (publ), reg.no. 556714-7607, with its registered office in Gothenburg, are hereby summoned to extraordinary general meeting to be held on 26 November 2019 at 10.00 a.m. CET at the offices of Vinge law firm, Stureplan 8, Stockholm, Sweden.Notification, etc.Shareholders who wish to participate in the general meeting must: firstly       be included in the shareholders’ register maintained by Euroclear Sweden AB as of 20 November 2019; and secondly notify the company of their participation in the general meeting no later than 20 November 2019. The

KONECRANES PLC INTERIM REPORT JANUARY-SEPTEMBER 2019

KONECRANES PLC INTERIM REPORT JANUARY-SEPTEMBER October 24, 2019 at 9:00am KONECRANES PLC INTERIM REPORT JANUARY-SEPTEMBER 2019 SOLID PERFORMANCE IN SERVICE AND PORT SOLUTIONS, WEAK PROFITABILITY IN INDUSTRIAL EQUIPMENT This release is a summary of Konecranes Plc’s January-September 2019 interim report. The complete report is attached to this release in pdf format and is also available on Konecranes’ website at www.konecranes.com. Konecranes has applied IFRS 16 Leases standard since January 1, 2019. The figures for comparison period 2018 have not been restated. Please refer to

ContextVision - Strong Q3 with solid sales, good inflow of new customers and first product in digital pathology enters beta-testing phase

STOCKHOLM – October 24, 2019 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, has seen a strong third quarter in 2019 as new customers have been added and the first product in digital pathology has entered the beta-testing phase. Q3 sales reached 23 MSEK and total sales are growing +5% compared to the third quarter last year. The operating result was positive 4.6 MSEK. “ContextVision continues to see solid sales as we build out our product portfolio and add new customers. ContextVision is committed to expanding the product

Boliden invests in electric trolley in Aitik and Kevitsa

Boliden has decided to invest SEK 300 m with the aim of expanding electrified transportation in Aitik and implementing the corresponding technology in Kevitsa. Investments will be made mainly during 2020-2021.Since 2018, a pilot project on electrified transportation has been conducted at Aitik. 700 meters of electric trolley line were installed and four mining trucks were converted with increased productivity and reduced diesel consumption as a result. Aitik is currently the only mine in an arctic climate where electric trolley has been installed. “We are now taking further steps to

Boliden's third quarter: Higher prices but major maintenance

Revenues for the period was SEK 11,170 m (12,510), with an operating profit, excluding revaluation of process inventory, of SEK 1,635 m (2,020). Free cash flow amounted to SEK -653 m (822).“Investments are proceeding as planned and production in our mines and zinc smelters has remained stable over the period. However, the quarter has been affected by major maintenance shutdowns in the copper smelters, a breakdown in the nickel line in Harjavalta and some disruptions in the logistics between mines and smelting plants”, says Mikael Staffas, President and CEO. The operating profit at

BE Group Q3 2019

Third quarter · Net sales decreased by 12% to SEK 977 M (1,111) · The underlying operating result amounted to SEK 13 M (26) · The operating result amounted to SEK 14 M (33) · Result after tax amounted to SEK 4 M (23) · Cash flow from operating activities amounted to SEK -14 M (-10) · Earnings per share amounted to SEK 0.30 (1.73) · Peter Andersson started as CEO and President · A new three-year credit agreement was signed · Decision was taken regarding investments in production equipment in Norrköping and an extension of existing rental agreement Statement

There are no items matching the current filter
There are no more items matching the current filter
Back to top